Skip to content

NeuroPath Comparative Validation Study Plan

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00393549
Enrollment
200
Registered
2006-10-30
Start date
2006-08-31
Completion date
2006-12-31
Last updated
2007-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome (CTS)

Keywords

Median Neuropathy at the wrist (MNW)

Brief summary

The purpose of the study is to compare the performance of the NeuroPath automated nerve conduction test with the standard of care manual test in the diagnosis of entrapment neuropathies.

Interventions

DEVICENeuroPath

Sponsors

Excel-Tech Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Symptomatic Inclusion Criteria: * sensory symptoms (numbness and/or tingling) in at least 2 of digits 1,2,3 and 4, in at least one hand, for at least 1 month, prior to the start of the clinical study. The sensory symptoms may be intermittent or constant, but if constant, there must have been a period of time during which the symptoms were intermittent. The numbness and tingling may be accompanied by pain, but pain alone is not sufficient to meet this first inclusion criteria. * Sensory symptoms (numbness and/or tingling) aggravated by at least 1 of the following: sleep, sustained hand or arm positioning, or repetitive actions of the hand. * Sensory symptoms (numbness and/or tingling) mitigated by at least 1 of the following: changes in hand posture, shaking the hand, or use of a wrist splint. * If pain is present, the wrist, hand, and finger pain is greater than elbow, shoulder, or neck pain if there is pain in any or all of those locations. Symptomatic

Exclusion criteria

* Sensory symptoms exclusive or predominatly in the little finger (D5) (ulnar neuropathy). * Neck pain or shoulder pain preceded the paresthesia in the digits (cervical radiculopathy and/or brachial plexopathy). * Numbness and/or tingling in the feet that preceded or accompanied the sensory symptoms in the hands (polyneuropathy). * Medical history and physical examination that indicates an explanation for the sensory symptoms which is more probable than CTS. For example, digital neuropathy, median nerve pathology proximal to the carpal tunnel, ulnar neuropathy, radical neuropathy, brachial plexopathy, cervical radiculopathy, spinal cord, brainstem or brain pathology, or a polyneuropathy. * Absence of 1st, 3rd, 4th or 5th digits * Open wounds at the measurement sites * Excessive sensitivity to electrical stimulation * Median nerve injection in the past 30 days * Prior carpal tunnel surgery * Patients who are susceptible to radio frequency noise - such as patients with pacemakers or patients that have electrical stimulators of any sort. Control Subject Inclusion Criteria: * Normal neurological examination Control Subject

Design outcomes

Primary

MeasureTime frame
Validity of the NeuroPath

Secondary

MeasureTime frame
Accuracy of the NeuroPath

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026